BULLETIN V2026-2763
XORTX THERAPEUTICS INC. ("XRTX")
BULLETIN TYPE: Delist
BULLETIN DATE: August 28, 2026
TSX Venture Tier 2 Company
Effective at the close of business September 1, 2026, the common shares of XORTX Therapeutics Inc. (the "Company") will be delisted from TSX Venture Exchange at the request of the Company. The Company will continue to trade on Nasdaq Stock Market.
For more information, please refer to the Company's press release dated June 12, 2026 and August 28, 2026.
_______________________________________
|
|
